Opendoor to Report Fourth Quarter 2023 Financial Results on February 15th, 2024
SAN FRANCISCO, Jan. 04, 2024 (GLOBE NEWSWIRE) — Opendoor Technologies Inc. (“Opendoor”) (Nasdaq: OPEN), a leading e-commerce platform for residential […]
Capital Product Partners L.P. Announces the Successful Delivery of the LNG Carrier ‘Axios II’
ATHENS, Greece, Jan. 04, 2024 (GLOBE NEWSWIRE) — Capital Product Partners L.P. (NASDAQ: CPLP), an international owner of ocean-going vessels, […]
LegalZoom Launches Beneficial Ownership Information Report to Help Businesses Satisfy New Federal Mandate under the Corporate Transparency Act
MOUNTAIN VIEW, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — LegalZoom, the No. 1 choice in online small business formations, announced […]
Stran & Company Appoints Ian Thomas Wall as Chief Information Officer
Quincy, MA, Jan. 04, 2024 (GLOBE NEWSWIRE) — Stran & Company, Inc. (“Stran” or the “Company”) (NASDAQ: SWAG; SWAGW), a […]
AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
VALENCIA, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company […]
Safe and Green Development Corporation Announces Update on LOI for Acquisition of Xene Real Estate AI Software
XENE Platform MIAMI, Fla, Jan. 04, 2024 (GLOBE NEWSWIRE) — Safe and Green Development Corporation (NASDAQ: SGD) (“SG Devco” or […]
African Agriculture Announces Multi-Year Supply Agreement with South Korea-Based Holding Company Dr. Kahn
New York, Jan. 04, 2024 (GLOBE NEWSWIRE) — African Agriculture Holdings Inc. (Nasdaq: AAGR), (“African Agriculture” or “the Company”) a […]
Oncternal Therapeutics Announces Reverse Stock Split
SAN DIEGO, Jan. 04, 2024 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the […]
GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients
Therapy Demonstrated Safety, Stabilization/Shrinkage of Treated Tumors Expanded Development for Monotherapy and Combination Therapy Anticipated ATLANTA, GA, Jan. 04, 2024 […]
SYLA Technologies Appoints Takuya Hanada as Chief Financial Officer
TOKYO, Jan. 04, 2024 (GLOBE NEWSWIRE) — SYLA Technologies Co., Ltd. (NASDAQ: SYT) (“SYLA” or “the Company”), operator of the […]
